{"product_id":"9783030891244","title":"Vaccines, Medicines and COVID-19 How Can WHO Be Given a Stronger Voice?","description":"\u003ch3\u003eSpringerBriefs in Public Health\u003c\/h3\u003e\u003ch1\u003eVaccines, Medicines and COVID-19\u003c\/h1\u003e\u003ch2\u003eHow Can WHO Be Given a Stronger Voice?\u003c\/h2\u003e\u003ch3\u003eGermán Velásquez\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Preventive Medicine\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cdiv\u003eThis open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? \u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003eThe considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. \u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eIn this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that wouldenable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered:\u003c\/div\u003e\n\u003cdiv\u003e\u003cul\u003e\n\u003cli\u003eCOVID-19 Vaccines: Between Ethics, Health and Economics\u003c\/li\u003e\n\u003cli\u003eMedicines and Intellectual Property: 10 Years of the WHO Global Strategy\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eRe-thinking Global and Local Manufacturing of Medical Products After COVID-19\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eRethinking R\u0026amp;D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eIntellectual Property and Access to Medicines and Vaccines\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe World Health Organization Reforms in the Time of COVID-19\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ci\u003eVaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice?\u003c\/i\u003e is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19.\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cdiv\u003e\n\u003cdiv\u003e\n\u003cb\u003eGermán Velásquez \u003c\/b\u003eis, since 2010, the Special Adviser for Policy and Health of the South Centre in Geneva, Switzerland, which is an intergovernmental think tank of and for developing countries.  \u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eUntil May 2010, he was Director of the World Health Organization (WHO) Secretariat on Public Health, Innovation and Intellectual Property, at the Director-General’s Office, in Geneva. He is a pioneer in the new area on health, intellectual property and access to medicines, and he represented WHO at the World Trade Organization (WTO) Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) from 2001 to 2010.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eGermán Velásquez graduated from Javeriana University, Bogotá, Colombia, with a degree in Philosophy and Humanities that was further complemented by a Master’s in Economics and a PhD in Health Economics from the Sorbonne University in Paris, France. In 2010, he received a PhD Honoris Causa on Public Health from the University of Caldas, Colombia. In October 2015, he received a Honoris Causa Doctorate from the Faculty of Medicine of the Complutense University of Madrid, Spain.\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003eGermán Velásquez is author or co-author of numerous publications on subjects such as health economics and medicines, health insurance schemes, globalisation, international trade agreements, intellectual property and access to medicines.  \u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e25 December 2021\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eSouth Centre\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eSpringer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9783030891244\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003ePaperback \/ softback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e117\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"South Centre","offers":[{"title":"Default Title","offer_id":44352470909068,"sku":"9783030891244","price":34.19,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783030891244.jpg?v=1780595155","url":"https:\/\/fh90cf-fv.myshopify.com\/products\/9783030891244","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}